SK280119B6 - Antivírusová aktívna farmaceutická emulzia - Google Patents

Antivírusová aktívna farmaceutická emulzia Download PDF

Info

Publication number
SK280119B6
SK280119B6 SK291-95A SK29195A SK280119B6 SK 280119 B6 SK280119 B6 SK 280119B6 SK 29195 A SK29195 A SK 29195A SK 280119 B6 SK280119 B6 SK 280119B6
Authority
SK
Slovakia
Prior art keywords
acyclovir
cream
water
skin
emulsion
Prior art date
Application number
SK291-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK29195A3 (en
Inventor
Knud E. Gebhard-Hansen
Soren B. Pedersen
Karen Bjornsdottir
Bodil G. Lissau
Borge I. F. Alhede
Original Assignee
A/S Gea Farmaceutisk Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A/S Gea Farmaceutisk Fabrik filed Critical A/S Gea Farmaceutisk Fabrik
Publication of SK29195A3 publication Critical patent/SK29195A3/sk
Publication of SK280119B6 publication Critical patent/SK280119B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK291-95A 1992-09-09 1993-09-09 Antivírusová aktívna farmaceutická emulzia SK280119B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (da) 1992-09-09 1992-09-09 Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
PCT/DK1993/000288 WO1994005258A1 (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof

Publications (2)

Publication Number Publication Date
SK29195A3 SK29195A3 (en) 1997-01-08
SK280119B6 true SK280119B6 (sk) 1999-08-06

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
SK291-95A SK280119B6 (sk) 1992-09-09 1993-09-09 Antivírusová aktívna farmaceutická emulzia

Country Status (27)

Country Link
EP (1) EP0662819B1 (bg)
JP (1) JPH08501089A (bg)
AT (1) ATE137113T1 (bg)
AU (1) AU4945393A (bg)
BG (1) BG62032B1 (bg)
BR (1) BR9307024A (bg)
CA (1) CA2142493A1 (bg)
CZ (1) CZ284007B6 (bg)
DE (1) DE69302396T2 (bg)
DK (1) DK169121B1 (bg)
EE (1) EE03088B1 (bg)
ES (1) ES2086235T3 (bg)
FI (1) FI112777B (bg)
GR (1) GR3019984T3 (bg)
HR (1) HRP931160B1 (bg)
HU (1) HUT72606A (bg)
LT (1) LT3056B (bg)
LV (1) LV10912B (bg)
NO (1) NO308234B1 (bg)
PL (1) PL172663B1 (bg)
RO (1) RO113306B1 (bg)
RU (1) RU2128503C1 (bg)
SI (1) SI9300469A (bg)
SK (1) SK280119B6 (bg)
UA (1) UA41897C2 (bg)
WO (1) WO1994005258A1 (bg)
ZA (1) ZA936661B (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (es) * 2004-01-08 2005-07-28 Universidad De Concepcion Formulacion topica de aciclovir
WO2005102282A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
US8927015B2 (en) 2006-04-12 2015-01-06 Emisphere Technologies, Inc. Formulations for delivering insulin
US20120142623A1 (en) * 2006-07-07 2012-06-07 Michael Lagunoff Compositions And Methods For Predicting Inhibitors Of Protein Targets
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
MX337166B (es) 2009-06-24 2016-02-15 Composicion topica que contiene ibuoprofeno.
CN103429247A (zh) 2010-12-29 2013-12-04 战略科学与技术有限责任公司 勃起功能障碍和其它适应症的治疗
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
DK111392D0 (da) 1992-09-09
ZA936661B (en) 1994-05-20
AU4945393A (en) 1994-03-29
NO308234B1 (no) 2000-08-21
HRP931160A2 (en) 1995-12-31
SI9300469A (en) 1994-03-31
LV10912A (lv) 1995-12-20
EP0662819A1 (en) 1995-07-19
DE69302396T2 (de) 1996-08-14
RU95110930A (ru) 1997-03-27
RU2128503C1 (ru) 1999-04-10
FI951086A0 (fi) 1995-03-08
WO1994005258A1 (en) 1994-03-17
CZ284007B6 (cs) 1998-07-15
LTIP959A (en) 1994-05-15
HU9500702D0 (en) 1995-04-28
PL307860A1 (en) 1995-06-26
BR9307024A (pt) 1999-06-29
FI951086A (fi) 1995-03-08
EP0662819B1 (en) 1996-04-24
PL172663B1 (pl) 1997-10-31
ES2086235T3 (es) 1996-06-16
NO950895L (no) 1995-03-08
UA41897C2 (uk) 2001-10-15
HUT72606A (en) 1996-05-28
CZ59995A3 (en) 1995-09-13
DK111392A (da) 1994-03-10
DE69302396D1 (de) 1996-05-30
EE03088B1 (et) 1998-06-15
JPH08501089A (ja) 1996-02-06
CA2142493A1 (en) 1994-03-17
SK29195A3 (en) 1997-01-08
LT3056B (en) 1994-10-25
RO113306B1 (ro) 1998-06-30
ATE137113T1 (de) 1996-05-15
BG99484A (bg) 1995-12-29
FI112777B (fi) 2004-01-15
DK169121B1 (da) 1994-08-22
HRP931160B1 (en) 1999-04-30
NO950895D0 (no) 1995-03-08
BG62032B1 (bg) 1999-01-29
GR3019984T3 (en) 1996-08-31
LV10912B (en) 1996-08-20

Similar Documents

Publication Publication Date Title
SK280119B6 (sk) Antivírusová aktívna farmaceutická emulzia
DE69003575T2 (de) Formulierung, ein Imidazo[4,5-c]Quinolin-Derivat enthaltend.
CA2152907C (en) Antiviral topical pharmaceutical compositions
US9724356B2 (en) Formulations of deoxycholic acid and salts thereof
NZ208597A (en) A penetration-enhancing topical pharmaceutical composition comprising 1-dodecylazacycloheptan-2-one
US4039664A (en) Topical griseofulvin composition and method
JP2555555B2 (ja) 抗真菌性外用製剤
US20020055542A1 (en) Topical aromatic fatty acid composition
US20020127249A1 (en) Novel formulation for use in pain management
US5128135A (en) Percutaneous or trans-mucosal absorption enhancers, preparations containing the enhancers, and a method of preparing thereof
WO2004030665A1 (en) Transparent gel composition, for the administration of diclofenac sodium through the skin
RU2543326C2 (ru) Фармацевтическая композиция для лечения зуда кожи
DE69001580T2 (de) Perkutane verabreichung von 3'-azido-3'-deoxythymidin.
CA1300508C (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
Berberian et al. The toxicology and biological properties of laureth 9 (a polyoxyethylene lauryl ether), a new spermicidal agent
AU2011201896A1 (en) Topical cromolyn formulations
RU2618462C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
US20080004235A1 (en) Topical compositions comprising one or more of 4-thiouridine, isomaltitol and uridine
WO2023016583A1 (zh) 一种芦可替尼组合物及其用途
RU2660353C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5
JP2951725B2 (ja) 爪白癬用外用組成物
HU230542B1 (hu) Dimetikont tartalmazó aciklovir készítmények